Member Info for B2HS2L

Saintsmith, - Does that apply to your NVYT shares then?

Thanks to Jvetch on another BB.

Hopefully everyone invested here is not looking for small quick profits, because there is

some interesting info in this article for the LTH's.

https://www.ft.com/content/f8f8b067-e663-4afe-90dd-6a243929af86

There’s absolutely nothing wrong with Innova tests. As long as you have a trained professional armed with a toffee hammer to batter the swabs in to the centre of your family’s skulls.
++++

ie

That hurts so much, I don't know whether I've had a frontal lobotomy or need a bottle in front of me.

Kaeren
https://www.bbc.co.uk/news/health-56252779

Note 'Top Stories' on top right corner

"Batch of home testing kits identified and each household being contacted, Matt Han(ock tells MP's"

1
Bluelight posted @ 08:38 this morning:

I just find it odd Blackrock is the only one to issue a TR!, and the wording of it has been Blackrock have informed us, as opposed to normally just a straight TR1. To me looks like Blackrock are proactively asking it to be notified, wheeas I imagine others have over 3% also (could be wrong, but I'd be surprised if they didn't) but are choosing not to. All a bit of a grey area, easy to cover your holdings by the look of it using the dual listing to hide it.
++++

2
Proverloop posted @ 09:18

Bluelight: the requirementent in France is 5%

https://www.amf-france.org/en/professionals/professional-investor/my-relations-amf/major-holding
++++

3
Half year 2020 results
Thu, 17th Sep 2020 07:00
RNS Number : 2380Z
Novacyt S.A.
17 September 2020

Novacyt S.A.
("Novacyt", the "Company" or the "Group")

Half year 2020 results

Transformational performance set to continue

Paris, France and Camberley, UK - 17 September 2020 - Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results..blah blah

Note : Novacyt (ALTERNEXT: ALNOV; AIM: NCYT)

++++

4
AGM Voting
Fri, 18th Sep 2020 07:00
RNS Number : 3572Z
Novacyt S.A.
18 September 2020

Novacyt S.A.

("Novacyt", the "Company" or the "Group")

AGM voting

Paris, France and Camberley, UK - 18 September 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics... blah blah

Note : Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT)

++++

From content of link in 2:

"Whenever a shareholder, acting alone or in concert, reaches, exceeds or falls below the legal thresholds of (i) 5%, 10%, 15%, 20%, 25%, 30%, 1/3, 50%, 2/3, 90% or 95% of the equity or voting rights of an issuer whose shares are admitted to trading on Euronext Paris, or (ii) 50% or 95% of the equity or voting rights of an issuer whose shares are admitted to trading on Euronext Growth, it must report this to the company and to the AMF"

++++

THEREFORE (ii) APPLIES TO NOVACYT:

For those waiting for share ownership notifications (TR1 equivalent) via French regs -

"50% or 95% of the equity or voting rights of an issuer whose shares are admitted to trading on Euronext Growth"

A binary idiot would be 111110.
I think he's a mutation.

Remember I posted this last night?

https://www.griproom.com/fun/about-griproom

Found at the bottom of this page:

Geoffrey Kelly 9 hours ago · 0 Likes

I read your comments about Blackrock - very interesting and disturbing.
I feel the same is happening at NCYT / ALNOV a company listed on AIM and the French Bourse

Also:

B2HS2L Just now (awaiting modulator approval)
I think you should consider David Stone writing a story about NCYT (ALNOV).
to see how the lessons learned in this article:

https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired

applies to NCYT

++++

Modulator did not approve.

Bluelight,
I would have thought that being dual listed, Novacyt has to comply with the rules of both exchanges :)

Does anyone have any links to articles discussing how companies can build a large position in another company, in ways that avoid advising the target company that share ownership has passed certain milestones, resulting in a TR1 being issued.
Thanks in advance.

1.butchers.bike
Listing the extensive number of Patents might also help value the company, and the contracts, covid & non-covid.

https://www.griproom.com/fun/about-griproom

Found at the bottom of this page:

Geoffrey Kelly 9 hours ago · 0 Likes

I read your comments about Blackrock - very interesting and disturbing.
I feel the same is happening at NCYT / ALNOV a company listed on AIM and the French Bourse

Also:

B2HS2L Just now (awaiting modulator approval)
I think you should consider David Stone writing a story about NCYT (ALNOV).
to see how the lessons learned in this article:

https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired

applies to NCYT

By the same griproom author on a similar subject:
https://www.griproom.com/fun/gilead-is-the-next-celgene-similarities-between-the-celgene-buyout-and-gilead

No offence taken Saintsmith.
I hope your research returns some other good stories you can share with us ;)

@11:37 today I posted

Thanks WiHe.
Plenty to ponder, on another GripRoom article here:

https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired

Laughing Out Loud

Guillermo Raimondo ex - Siemens Healthineers:

Executive Vice President Global Marketing, Sales & Communications Siemens Healthineers Diagnostics
Dates Employed 2018 – end of 2020
Employment Duration 2 yrs

President Latin America
Dates Employed 2015 – 2018
Employment Duration 3 yrs
Location Santiago, Chile

Siemens - 21 years.

+++++

James McCarthy - CFO Flint Group - (May 2018 to March 2020), then returned to self employed as an Independent Consultant.

Unsure why he did not last that long in Flint Group (colour Printers).

Thanks WiHe.
Plenty to ponder, on another GripRoom article here:

https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired

https://www.aol.co.uk/news/first-cases-worrying-manaus-variant-165749216.html

Public Health England (PHE) have identified the first UK cases of the Manaus variant of coronavirus, a new strain that may spread more rapidly and may respond less well to existing vaccines.

Up to six cases of the concerning variant first detected in the Brazilian city have been identified in Britain, three in England and three in Scotland, it emerged on Sunday.

The first two cases of the P.1 strain are from one household in South Gloucestershire with a history of travel to Brazil but the third is not linked.

The whereabouts of that individual is unknown, as PHE says the person did not complete their test registration card so follow-up details are unavailable.

Officials are asking anyone who took a test on February 12 or 13 and who has not received a result or has an uncompleted test registration card to come forward immediately.

Dr Susan Hopkins, PHE’s strategic response director for Covid-19, said: “We have identified these cases thanks to the UK’s advanced sequencing capabilities which means we are finding more variants and mutations than many other countries and are therefore able to take action quickly.

“The important thing to remember is that Covid-19, no matter what variant it is, spreads in the same way. That means the measures to stop it spreading do not change.”

A community support officer speaks to people enjoying the sunshine on Brighton beach in Sussex. Picture date: Sunday February 28, 2021.
31 PHOTOS
Covid in the UK
See gallery
The World Health Organisation has been informed of the cases, which has been designated “of concern” as it shares key mutations with the variant detected in South Africa.

More work is needed, but there are concerns that the existing vaccines may be less effective against the Manaus stran.

In South Gloucestershire, one of the individuals had travelled back from Brazil in mid-February, before the Government introduced the quarantine hotel policy.

So they isolated at home with the rest of their household. One member developed symptoms, officials said, before getting a test.

There were three other further cases in that household, two of which were confirmed as the Manaus variant with genetic sequencing, but the other two were not sequenced.

The remaining unlocated case is not believed to be linked to the others because the virus was found to have slight genetic differences.
++++
Possibly a busy weekend for the NCYT genomics sequencing team?

Wilson -
I don't recall politics being discussed in the News of the World, - just who was found in bed with who!
It was known as NewsoftheScrews - and it wasn't full of prison officers.

We are going to need a good partner for manufacture and distribution of SNGsig assays in USA.
This is the team that can assist us with that journey :)

Primerdesigns partnership with Applied Microarrays announced 13.09.2018 -

https://www.lse.co.uk/rns/NCYT/novacyt-partners-with-applied-microarrays-qbb4zadobpqrevf.html

Paris, France and Camberley, UK - 13 September 2018 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing division, Primerdesign Ltd. (Primerdesign), has partnered with Applied Microarrays, Inc. (AMI), a company that specialises in providing customised microarrays and manufacturing point-of-care (POC) and high throughput DNA and protein arrays, to offer comprehensive single nucleotide polymorphism (SNP) assay development.

Confirmation @

https://appliedmicroarrays.com/array-services/array-design-optimization/

You maybe right Oriens, - but it is the continual flow of market disruptive products that is the interest.
Winterplex, Exsig direct, and now SNPsig.

The use of the licensed (2012) algorithm from Applied Microarrays, that allows the development of accurate assays in record time was a master stroke :)